A3P Biomedical - Stockholm, Sweden

A3P Biomedical is a leader in prostate cancer diagnosis and treatment. Their specialty is advanced prostate cancer diagnostics, and their cutting-edge product, Stockholm3, is a clinically and commercially validated blood test for the early detection of aggressive prostate cancer. This test combines protein markers, genetic markers, and clinical data into a proprietary algorithm to accurately detect aggressive prostate cancer in its early stages.